Yoon Jae Choi

Yoon Jae Choi, MD is an Assistant Professor in the Department of Neurology at the University of California, Irvine School of Medicine. She is a board-certified neuro-oncologist with expertise in diagnosing and treating primary brain tumors and metastatic central nervous system (CNS) malignancies.

• Education: Korea University College of Medicine (South Korea), University of Chicago Medical Center residency, UCLA and Rush University fellowships
• Clinical Interests: Neurophysiology, neurological complications of metastatic tumors, paraneoplastic syndromes

Her research focuses on neuro-oncology and cancer treatment, particularly in Glioblastoma Multiforme. She co-authored a 2018 phase 2 clinical trial evaluating the safety and efficacy of bortezomib combined with radiation therapy and temozolomide, demonstrating improved progression-free and overall survival rates, especially in MGMT-methylated patients. The study highlighted the potential of proteasome inhibitors in glioblastoma therapy but emphasized the need for larger cohorts.

Dr. Choi is affiliated with professional organizations including the American Academy of Neurology, Society for Neuro-Oncology, and American Society of Clinical Oncology. Her clinical practice emphasizes patient-centered care, as evidenced by numerous positive patient reviews praising her thoroughness, empathy, and clear communication.